Lan-bo Chen

Biography

Lan-Bo Chen, Ph.D. Dr. Chen is Professor Emeritus of Pathology at Harvard Medical School. He received his B.S. in chemistry from National Taiwan University, Ph.D. in cell biology from the Massachusetts Institute of Technology, postdoctoral training under Dr. James D. Watson (Nobel Laureate) at Cold Spring Harbor Laboratories, was recruited by Dr. Baruj Benacerraf (Nobel Laureate) to Harvard Medical School and elected as an academician of the Academia Sinica of Taiwan. He is the author of over 250 academic publications and is the founder of several successful biotechnology companies and ventures, including Fuji ImmunoPharmaceuticals Corp. and Shionogi BioResearch Corp. (both with Nobel laureate Dr. Susumu Tonegawa); Caxton Life Science Partners; Taiwan Global BioFund; TaiMed Biologics; Mevion Medical Systems; Cancer BioScience; Cancer Genetics; Kava Pharmaceuticals; SinglePixel BioMedical; Quercegen Pharma; Madrigal/Synta Pharmaceuticals and Sequential Medicine. Dr. Chen has served as a Senior Consultant for numerous large pharmaceutical firms, and has led the development or consulted for more than a dozen drugs and drug candidates.

Research Interest

 pathology